dexketoprofen trometamol has been researched along with metoclopramide in 2 studies
| Studies (dexketoprofen trometamol) | Trials (dexketoprofen trometamol) | Recent Studies (post-2010) (dexketoprofen trometamol) | Studies (metoclopramide) | Trials (metoclopramide) | Recent Studies (post-2010) (metoclopramide) |
|---|---|---|---|---|---|
| 190 | 99 | 130 | 5,044 | 1,216 | 623 |
| Protein | Taxonomy | dexketoprofen trometamol (IC50) | metoclopramide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.383 | |
| Myeloperoxidase | Homo sapiens (human) | 0.35 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.721 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.127 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 7.8 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.675 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.383 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 7.8 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.2 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.88 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.63 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.6237 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cevik, Y; Çorbacioglu, ŞK; Dagar, S; Emektar, E; Korucu, O | 1 |
| Gulacti, U; Lok, U; Turgut, K; Yavuz, E | 1 |
2 trial(s) available for dexketoprofen trometamol and metoclopramide
| Article | Year |
|---|---|
The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments.
Topics: Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Bupivacaine; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Ketoprofen; Male; Metoclopramide; Middle Aged; Migraine Disorders; Nerve Block; Prospective Studies; Tromethamine | 2018 |
Intravenous metoclopramide versus dexketoprofen trometamol versus metoclopramide+ dexketoprofen trometamol in acute migraine attack in the emergency department: A randomized double-blind controlled trial.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Ketoprofen; Male; Metoclopramide; Middle Aged; Migraine Disorders; Pain Measurement; Prospective Studies; Time Factors; Tromethamine; Visual Analog Scale | 2020 |